In This Issue
- ASH 2020: Reflections from Our New Editors
- Allogeneic Stem Cell Transplant for Older MDS Patients
- Arming Memory-Like NK Cells with a Novel CAR to Target NPM1-Mutated Acute Myeloid Leukemia
- Driving Towards a Cure? CAR T-Cells for Indolent B-Cell Non-Hodgkin Lymphoma
- High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse
Additional Resources
Dana-Farber at ASH 2020 Annual Meeting
Adult Stem Cell Transplantation Program
Cellular Therapies Program
Adult Leukemia Program
Adult Lymphoma Program
Multiple Myeloma Program